CN Patent

CN112839649A — Cxcr4抑制剂组合物以及制备和使用的方法

Assigned to X4 Pharmaceuticals Inc · Expires 2021-05-25 · 5y expired

What this patent protects

本发明提供了用于治疗、预防或改善与趋化因子受体(例如CXCR4)有关的疾病、病症或病状的组合物和使用方法。

USPTO Abstract

本发明提供了用于治疗、预防或改善与趋化因子受体(例如CXCR4)有关的疾病、病症或病状的组合物和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112839649A
Jurisdiction
CN
Classification
—
Expires
2021-05-25
Drug substance claim
No
Drug product claim
No
Assignee
X4 Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.